← Back to Press Releases October 31, 2025 Non-opioid AAV9-miRNA Gene Therapy to Silence SCN9A Achieves Durable Pain Control and Target Engagement in Non-human Primates Share Post Email Copy Link Cell-Selective Targeting and Regulation The precision gene therapies being developed at Encoded are potentially capable of targeting specific cell types or levels of expression to address a range of disease mechanisms. Learn more Cell-Selective Targeting and Regulation The precision gene therapies being developed at Encoded are potentially capable of targeting specific cell types or levels of expression to address a range of disease mechanisms. Learn more
